References
- Wenzlau J. M., Juhl K., Yu L., . The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA. 2007; 104:17040–17045.
- Nielsen L. B., Vaziri-Sani F., Porksen S., . Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity. 2011; 44:616–623.
- Wenzlau J. M., Liu Y., Yu L., . A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes. 2008; 57:2693–2697.
- Andersson C., Larsson K., Vaziri-Sani F., . The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity. 2011; 44:394–405.
- Kawasaki E., Nakamura K., Kuriya G., . Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients. Clin. Immunol.. 2011; 138:146–153.
- Lampasona V., Petrone A., Tiberti C., . Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care. 2010; 33:104–108.
- Trabucchi A., Faccinetti N. I., Guerra L. L., . Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity. 2012; 45:137–142.
- Chimienti F., Devergnas S., Favier A., Seve M.. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes. 2004; 53:2330–2337.
- Wenzlau J. M., Frisch L. M., Gardner T. J., . Novel antigens in type 1 diabetes: the importance of ZnT8. Curr. Diab. Rep.. 2009; 9:105–112.
- Scott L. J., Mohlke K. L., Bonnycastle L. L., . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316:1341–1345.
- Staiger H., Machicao F., Stefan N., . Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One. 2007; 2:e832.
- Pettersen E., Skorpen F., Kvaløy K., Midthjell K., Grill V.. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trondelag Health Study. Diabetes59:302–310.
- Xu K., Zha M., Wu X., . Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes—a meta-analysis. Diabetes Res. Clin. Pract.. 2011; 91:195–202.
- Achenbach P., Lampasona V., Landherr U., . Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009; 52:1881–1888.
- Holmen J., Midthjell K., Krüger Ø., . The Nord-Trøndelag Health Study 1995–97 (HUNT2): objectives, contents, methods and participation. Norsk Epidemiologi. 2003; 13:19–32.
- Sørgjerd E. P., Skorpen F., Kvaløy K., Midthjell K., Grill V.. Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway. Diabetologia. 2012; 55:1310–1318.
- Vaziri-Sani F., Oak S., Radtke J., . ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity. 2010; 43:598–606.
- Wenzlau J. M., Walter M., Gardner T. J., . Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J. Clin. Endocrinol. Metab.. 2010; 95:4712–4719.
- Kawasaki E., Uga M., Nakamura K., . Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia. 2008; 51:2299–2302.